Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Acamprosate Generic Name & Formulations
Legal Class
Rx
General Description
Acamprosate calcium 333mg; e-c tabs.
Pharmacological Class
GABA/taurine analogue.
How Supplied
Contact supplier
Manufacturer
Acamprosate Indications
Indications
Maintenance of abstinence from alcohol in alcohol-dependent patients who are abstinent at treatment initiation, in conjunction with psychosocial support.
Acamprosate Dosage and Administration
Adult
666mg 3 times daily. Renal impairment (CrCl 30–50mL/min): initially 333mg 3 times daily. Begin therapy during abstinence; continue during relapse.
Children
Not established.
Acamprosate Contraindications
Contraindications
Severe renal impairment (CrCl≤30mL/min). Sulfite allergy.
Acamprosate Boxed Warnings
Not Applicable
Acamprosate Warnings/Precautions
Warnings/Precautions
Moderate renal impairment (CrCl 31–50mL/min); reduce dose. Not a treatment for withdrawal symptoms. Monitor for suicidal ideation. Elderly. Labor & delivery. Pregnancy (Cat.C). Nursing mothers.
Acamprosate Pharmacokinetics
See Literature
Acamprosate Interactions
Not Applicable
Acamprosate Adverse Reactions
Adverse Reactions
GI upset, myalgia/arthralgia, headache, rash, syncope, impotence, edema, palpitations; rare: kidney failure, suicidality.
Acamprosate Clinical Trials
See Literature
Acamprosate Note
Notes
Formerly known under the brand name Campral.
Acamprosate Patient Counseling
See Literature
